Understanding the role of B cells in kidney transplant rejection
Intrarenal B cells in acute kidney allograft rejection
This study is looking at how certain immune cells called B cells might play a role in kidney transplant rejection, especially when usual treatments don't work, to help find better ways to support patients facing this challenge.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-10763813 on NIH RePORTER |
What this research studies
This research investigates how B cells contribute to acute rejection of kidney transplants, particularly in cases where standard treatments fail. By analyzing kidney biopsies, the study aims to identify specific characteristics of B cells that may predict poor transplant outcomes. The researchers are employing innovative techniques to examine the interactions between B cells and other immune cells in the kidney, which could lead to new treatment strategies for patients experiencing transplant rejection.
Who could benefit from this research
Good fit: Ideal candidates for this research are kidney transplant recipients who are experiencing acute rejection, particularly those resistant to standard immunosuppressive therapies.
Not a fit: Patients who have not undergone kidney transplantation or those with stable graft function are unlikely to benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment options for kidney transplant recipients facing rejection, potentially enhancing graft survival.
How similar studies have performed: Previous studies have shown varying results regarding the role of B cells in transplant rejection, indicating that this area of research is still evolving and holds potential for new insights.
Where this research is happening
Chicago, United States
- University of Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Chong, Anita S — University of Chicago
- Study coordinator: Chong, Anita S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.